Tetracyclines are broad-spectrum antibiotics with considerable activity against both gram-positive and gram-negative bacteria and exert a bacteriostatic effect by inhibiting protein synthesis. Widespread resistance to tetracycline has limited its clinical effectiveness against some groups of bacteria, especially streptococci. Unfortunately, the occurrence of tetracycline resistance is widespread among a number of Lancefield groups of streptococci of human and animal origin (2, 4, 15) . We have previously identified three genetically distinct tetracycline resistance determinants in streptococci (3) . These determinants, designated tetL, tetM, and tetN, were distinguished by their differential sensitivities to tetracycline antibiotics and DNA hybridization patterns. However, the basis for resistance due to these determinants has not been previously examined.
Previous analysis of naturally occurring tetracycline resistance in a number of other bacterial systems, e.g., Escherichia coli (12) , Staphylococcus aureus (19) , Bacteroides fragilis (7) , and Bacillus subtilis (6) , has indicated that drug resistance is mediated by decreased accumulation of the drug by resistant cells. The single reported exception to this generality has been in Streptomyces rimosus (18) , the organism which produces tetracycline.
In this report, we characterize the basis of resistance in cells containing the streptococcal tetL, tetM, and tetN resistance determinants. This work demonstrated that, in contrast to sensitive cells, streptococci containing tetL do not accumulate tetracycline. However, cells containing tetM or tetN determinants transport tetracycline at the same rate and to the same extent as do sensitive cells. This idea is consistent with the demonstration that cell-free systems derived from tetM or tetN are resistant to tetracycline in vitro. Resistance in strains bearing the latter determinants apparently reflects elaboration of a factor rendering protein synthesis insensitive to intracellular drug.
(A preliminary report of this work has appeared [V. Burdett, Plasmid 13:223, 1984] .) MATERIALS 
AND METHODS
Strains. For transport experiments, Streptococcusfaecalis (faecium) ATCC 9790, which was obtained from the American Type Culture Collection, was used. A spontaneous mutant resistant to rifampin (ATCC 9790r) was isolated by plating a 10-fold concentrated broth culture on solid medium containing 100 ,ug of the antibiotic per ml. ATCC 9790r derivatives containing plasmids representative of tetL (pMV158), tetM (pAM211), and tetN (pMV120) were introduced by conjugation from JH203(pMV158 pIP501), JH203(pAM211), and JH203(pMV120) (3).
Media. S. faecalis 9790 and its tetracycline-resistant derivatives were routinely grown in KTY medium which contained 1% K2HPO4, 1% tryptone (Difco Laboratories, Detroit, Mich.), 0.5% yeast extract (Difco), and 1% glucose (10) . Medium KMTY is reported to have low phosphate content (11) and was used to investigate the effects of arsenate on tetracycline accumulation.
Determination of antibiotic resistance. The susceptibility of S. faecalis isolates to tetracycline and minocycline were determined with serial dilutions of antibiotic (22) Reagents. Valinomycin and N,N'-dicyclohexylcarbodiimide were purchased from Sigma Chemical Company (St. Louis, Mo.); nigericin and carbonyl cyanide m-chlorophenylhydrazone (CCCP) were from Calbiochem-Behring (La Jolla, Calif.). All the foregoing were added in ethanol such that the final concentration of ethanol never exceeded 0.1%. All antibiotics were purchased from Sigma. Aqueous stocks of tetracycline (10 mg/ml) and nonaqueous stocks of minocycline (5 mg/ml in methanol) were prepared fresh daily. Concentrations were determined spectrophotometrically (14 (12) , S. aureus (19) , B. fragilis (7), and B. subtilis (6) have demonstrated reduced accumulation of tetracycline by resistant cells. In E. coli, this has been shown to be the result of an energy-dependent efflux system. Since the mechanism of tetracycline resistance has not been previously examined in streptococci, uptake of tetracycline was explored in S. faecalis ATCC 9790r and derivatives containing the three tetracycline resistance determinants (tetL, tetM, and tetN).
Because of their structural and metabolic simplicity, streptococci are well suited for studies involving possible transport phenomena. S. faecalis lacks internal energy reserves, does not carry out oxidative phosphorylation, and is sensitive to ionophores and other agents which de-energize the membrane (5). During ordinary growth, the cells lack cytochromes and rely entirely on glycolysis and substrate level phosphorylation for metabolic energy (9) . S. faecalis (faecium) ATCC 9790 has been used extensively to study transport of metabolites and cations and thus provides a well-characterized background for studying tetracycline transport.
ATCC 9790r and derivatives containing tetL, tetM, and tetN plasmids exhibited patterns of resistance to tetracycline antibiotics similar to those of other streptococcal strains (3).
In particular, ATCC 9790r containing pMV158 (tetL) had an MIC of 20 p.g of tetracycline per ml, 40-fold more resistant than the sensitive host, and did not mediate resistance to minocycline, a finding consistent with previous results in other genetic backgrounds (3). Class M (pAM211) and N (pMV120) plasmids mediated high-level resistance to tetracycline up to 200 pg/ml and increased resistance to minocycline from 0.04 to 10 p.g/ml. Pregrowth of any of the resistant strains in the presence of subinhibitory concentrations of tetracycline had no effect on the resistance levels observed. This is in contrast to E. coli, in which the inducible resistance determinants showed increased resistance when the cells were first exposed to a subinhibitory concentration of tetracycline (8) .
Based on our initial analysis of the effects of tetracycline on growth rate, we reported that tetL, tetM, and tetN were constitutively expressed (2) . However, experiments described below suggested that exposure of cells containing tetM or tetN to tetracycline increased the level of resistant protein synthesis. Consequently, we reinvestigated this question at the level of growth response (Fig. 1 ) and found that, by careful examination of the growth rates of cultures VOL. 165, 1986 on November 6, 2017 by guest http://jb.asm.org/ Downloaded from For each strain, two cultures were grown, and tetracycline (20 ,ug/ml) was added to one flask (0) at the time indicated by the arrow but omitted from the second (0). Growth was recorded as an increase in the A590 of the culture. challenged with tetracycline with or without prior exposure to subinhibitory concentrations of the drug, pMV158 (tetL) mediated constitutive resistance (data not shown), whereas pAM211 (tetM) and pMV120 (tetN) mediated inducible resistance. Induction of tetM and tetN was clearly observed in about half of the experiments, but higher levels of resistant protein synthesis were consistently observed when cells containing these determinants were grown in tetracycline (see below).
Transport of tetracycline by ATCC 9790r. Uptake of tetracycline in the sensitive strain (ATCC 9790r) exhibited properties of active transport (Fig. 2) . The drug was accumulated against a concentration gradient, a phenomenon which was dependent on the presence of glucose as an energy source. Furthermore, as shown below, no modification of accumulated drug was detectable. In addition, uptake was reversible, as evidenced by exchange upon transfer of cells preloaded with labeled tetracycline to fresh medium with or without excess unlabeled tetracycline (Fig. 2d) .
N,N'-dicyclohexylcarbodiimide, nigericin, CCCP, arsenate, and valinomycin can, under specific conditions, alter the ability of cells to carry out transport functions. In the presence of K+, valinomycin was without effect on the rate or extent of uptake of tetracycline. However, under identical conditions, and as shown by others (1), we found that transport of threonine was blocked (data not shown). Since this ionophore collapses membrane electrical potential in the presence of potassium, these results indicate that, in contrast to threonine transport, membrane electrical potential appears to be unimportant for tetracycline transport. In contrast, N,N'-dicyclohexylcarbodiimide and arsenate, which interfere with the ability of streptococci to maintain a proton motive force across the cell membrane (9), inhibit active accumulation of tetracycline by sensitive cells. Agents which collapse the transmembrane pH gradient, such as CCCP (Fig. 2c) and nigericin (Fig. 2b) , also blocked the accumulation of tetracycline, and CCCP induced rapid loss of tetracycline from cells which had previously been allowed to accumulate the drug (Fig. 2c) . These results suggest that transport of tetracycline in streptococci is driven by the Tetracycline accumulation in resistant cells. As previously reported, strains bearing pMV158 (tetL) remain sensitive to minocycline, whereas those containing pAM211 (tetM) and pMV120 (tetN) are minocycline resistant. These differences in susceptibility suggested differences in the resistance mechanism between tetL on the one hand and tetM and tetN on the other. When tetracycline accumulation was nmeasured in ATCC 9790r cells containing tetL, tetM, or tetN, two patterns of accumulation were observed (Fig. 3) . tetLcontaining cells did not accumulate tetracycline over background levels observed in all cell types in the absence of glucose. However, tetracycline accumulation by cells containing tetM or tetN was comparable in both rate and extent to that observed in sensitive cells. As in sensitive cells, this accumulation was energy dependent, as shown by the requirement for added glucose.
Analysis of intracellular tetracycline. Energy-dependent uptake of tetracycline by resistant cells raised the possibility of drug modification within tetM and tetN cells to yield a derivative which was less active as an inhibitor of protein synthesis. However could be freely exchanged with tetracycline in the medium (Fig. 2d) , and the activity of tetracycline recovered from sterile culture supernatants of resistant strains grown in the presence of tetracycline retained full biological activity (Fig.  4) . In addition, accumulated tetracycline was extracted from within sensitive cells and tetM and tetN resistant cells and examined chromatographically (Fig. 5) . As can be seen, radioactive tetracycline extracted from sensitive and resistant cells comigrated with species found in commercial samples of the unlabeled drug and radiolabeled tetracycline carried through the same extraction procedure. These findings indicate that resistance of cells harboring tetM and tetN is not mediated by drug modification.
Tetracycline-resistant protein synthesis in vitro. The foregoing results suggested that tetracycline resistance in tetM and tetN cells might involve a mechanism in which protein synthesis is rendered insensitive to the presence of chemically authentic tetracycline. This possibility was addressed by analysis of protein synthesis in cell-free fractions prepared from drug-sensitive and -resistant cell types (Fig. 6 ). Protein synthesis in extracts prepared from sensitive ATCC 9790r or those containing the tetL uptake resistance system were very sensitive to inhibition by added tetracycline. In both cases, synthesis in extracts was inhibited 50% by tetracycline concentrations of about 10 ,uM. This can be compared with an intracellular concentration in excess of 100 ,uM achieved by transport of the drug into sensitive cells (Fig. 2) . In contrast, 50% inhibition of in vitro synthesis in (3) . Although these determinants were originally distinguished genetically and by virtue of differential resistance to tetracycline and minocycline, it is shown here that tetL is also distinguished from tetM, tetN, or both at the level of mechanism of resistance. Indeed, this work describes a mechanism of R-factor-associated tetracycline resistance in a clinically significant pathogen that has the unusual property of being mediated at the level of protein synthesis.
It is known in other systems that energy-dependent transport of tetracycline is blocked in resistant strains, owing to the presence of a plasmid-mediated efflux system (6, 7, 12, 19) . The streptococcal tetL determinant presumably mediates resistance by the familiar efflux system (unpublished data). Indeed, this appears to be the case; not only is accumulation of tetracycline blocked in the streptococcal background, but when the cloned tetL determinant is tested in E. coli, it can be shown that tetL specifies an energydependent efflux system (V. Burdett and S. B. Levy, upublished data).
Moreover, it is shown here that streptococci containing tetM or tetN possess a mechanisni of tetracycline resistance in which transport of the antibiotic is unaffected by the presence of these resistance determinants. Tetracycline is accumulated at the same rate and to the same extent as it is in sensitive cells. Furthermore, the antibiotic recovered from inside the cells appears to be unmodified, and drug which has been incubated with extracts retains its biological activity. However, when cell-free extracts were tested in an in vitro protein-synthesizing system, it was found that protein synthesis in extracts prepared from cells carrying tetM or tetN was resistant to tetracycline, and this resistance could be increased 10-fold by growth in the presence of tetracycline. Inducibility in this system was difficult to determine by the more usual approaches, such as growth challenge experiments or by looking for increased resistance levels after exposure to antibiotic, and these have not been useful in evaluating inducibility in streptococci.
There are several possible explanations for the resistance of in vitro protein synthesis to tetracycline seen here. One is that resistance reflects functional alteration of the ribosome with respect to RNA or protein constituents. Alternatively, tetracycline could be sequestered by a tetracycline-binding protein within the cell, which prevents subsequeht interaction of the drug with its ribosomal target. In this light it is interesting to note that in two organisms which produce tetracycline antibiotics, Streptomyces aureofaciens (13) 
